EGFR (T790M C797S), DEL 746-750, GST-Tag Recombinant
Catalog #
79434
$410
*
●
●
Purchase
Description
Recombinant human EGFR (epidermal growth factor receptor, also known as HER1), encompassing amino acids 668-end and containing the tyrosine kinase domain. The protein contains deletion 746-750 and mutations T790M and C797S. This construct contains an N-terminal GST-tag. The recombinant protein was affinity purified and is kinase-active.
This product has been cited 1 time.
●
Synonyms
Epidermal growth factor receptor, ERBB, ERBB1, HER1, c-ErbB-1
●
Product Data Gallery
Product Info
Storage and Usage
Citations1
Species
Human
Construct
EGFR (GST-668-end)
Mutation
Del746-750, T790M, C797S
Host Species/Expression System
Sf9 insect cells
Purity
80%
Format
Aqueous buffer solution
Formulation
50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM glutathione, 0.1 mM EDTA, 0.25 mM DTT, 0.1 mM PMSF, 25% glycerol
MW
79 kDa + glycans
Amino Acids
668-end
Glycosylation
This protein runs at a higher MW by SDS-PAGE due to glycosylation.
Specific Activity
17 pmol/min/µg
Genbank #
NM_005228
UniProt #
P00533
Background
EGFR is the receptor for members of the EGF family and is a transmembrane glycoprotein that has tyrosine kinase activity. Binding of epidermal growth factor to EGFR induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation, differentiation, motility, and cell survival (1). Activation of EGFR triggers mitogenic signaling in gastrointestinal mucosa, and its expression is upregulated in colon cancers and most neoplasms (2). Activation of EGFR triggers activation of the ERK-signaling pathway in normal gastric epithelial and colon cancer cell lines. Inactivation of EGFR with selective inhibitors significantly reduces ERK2 activation, c-fos mRNA expression and cell proliferation.
References
1. Wang, K., et al., J Biol. Chem 2004;279:53848-53856.
2. Kobayashi, S., et al., New Eng. J. Med. 2005;325:786-792.